 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval( Y3 T1 F5 `4 P( c8 N( b% i
8 C! H: c' g$ s" xEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
: H4 Y: c- v0 G& z" j6 b + l$ W& s9 z/ o9 B
BY THE EDMONTON JOURNAL FEBRUARY 16, 20075 I( Y* {* T' G# g/ j- M/ l0 P. A3 ~
7 _0 G3 o5 I j* `8 d8 c
m; D8 s: ~% b s; {3 pEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
& R0 }+ W) u q- J; A
: A, N! i& T/ \, |' g- F$ i7 @4 MThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."! K' H2 S) j; p
% G6 _# O- f) n. s) F6 i0 L& XThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product./ b6 K5 w8 T/ p4 r
4 y; P, D. Q4 l) } s* \ |It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
$ r: o1 S$ t. C. @% S
9 y4 A( |6 F) S( G- j+ XIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.1 B- x2 ~/ f s$ v! q4 a
: `, I6 K7 _1 G; E"As a scientist, it's one of the highlights of my CAREER," Shan said.1 g; ^4 d* @6 _ E
6 R( r3 }! [" X
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
4 V b& u* _9 S/ p# Z. ?' C; e3 G4 t# v* r" K" a
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
0 {4 I6 ]) r6 @! x- M+ V7 v$ P: e8 }0 a6 D+ |9 Z+ y9 S
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
+ }! @& ]" G; A# W. L2 k0 _6 ?
1 l' R3 A* Z+ CThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.& Q d5 [; p! X, n3 y4 o- v" @+ d( f
5 r1 c$ k0 Y4 b. l0 Y# ?* A% ?6 C4 h" a ~: V, a
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
A! u: W, i7 k5 j6 _
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
